Jane Street
MRKR icon

Jane Street’s Marker Therapeutics MRKR Stock Holding History

Jane Street’s Portfolio MRKR Stock Details MRKR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-2,120
Closed -$36K – 10565
2021
Q3 		$36K Sell
2,120
-1,440
-40% -$29.5K ﹤0.01% 9638
2021
Q2 		$99K Buy
+3,560
New +$93.7K ﹤0.01% 9270

Other funds holding MRKR

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Jane Street's MRKR Position: Q1 2026 in Review

Jane Street reduced its Marker Therapeutics (MRKR) stake by 10% in Q1 2026, selling an estimated $6.69K and leaving 36,303 shares worth $47.2K. The position accounts for ﹤0.01% of the portfolio, ranked #10992.

Jane Street first reported a position in MRKR in Q3 2020 and has held it in 9 quarters since. The position peaked at $81K in Q4 2021. 35 funds tracked by Wall St. Rank hold MRKR as of Q1 2026.

  • Jane Street held 36,303 shares of Marker Therapeutics worth $47.2K as of Q1 2026.
  • Jane Street sold 4,215 Marker Therapeutics shares in Q1 2026, an estimated $6.69K.
  • Marker Therapeutics made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #10992 holding.
  • Jane Street first reported a position in Marker Therapeutics in Q3 2020 and has held it in 9 quarters since.
  • Jane Street's Marker Therapeutics position peaked at $81K in Q4 2021.
  • 35 funds tracked by Wall St. Rank held Marker Therapeutics as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.